Background: Increased physical activity may be advantageous for weight loss.
Introduction
A negative energy balance is essential for weight loss in overweight or obese people. Current treatment strategies consistently recommend a combination of a decrease in daily energy intake and an increase in energy expenditure by physical activity and have the primary objectives of reducing body fat mass (FM) and attenuating cardiovascular disease (CVD) risks (1) . Importantly, a negative energy balance should be induced by a hypoenergetic diet (DI), whereas the energetic effects of physical activity are often overestimated (1) (2) (3) . However, physical activity reduces cardiometabolic risks and favorably alters body composition by maintaining skeletal muscle as the main component of fat-free mass (FFM) (4) (5) (6) (7) . FFM, in turn, is the major determinant of resting energy expenditure (REE) (8, 9) .
During body weight reduction programs, a decrease in weight-loss rate over time is often observed (10) (11) (12) (13) , which has been explained by a decline in REE because of an initial disproportionate loss of muscle mass. However, previous findings indicate that the metabolic rate of major organs, primarily the brain, heart, liver, and kidney, rather than that of skeletal muscle alone, may largely account for the REE (14, 15) . Consistent with this observation, it was shown that part of the decline in REE occurs independently of the degree of weight loss and may be related to neuroendocrine factors, such as thyroid hormones (16) (17) (18) (19) . It is not fully understood whether these endocrine variables and their effects on REE may also be influenced by physical activity, or whether such possible effects may be dependent on the vigor and/or duration of exercise.
There is evidence that higher intensities of aerobic and weight training lead to more favorable changes in body composition and CVD risk (7, 20) . However, for most overweight and obese individuals, higher-intensity training is difficult to realize because of orthopedic problems, low cardiovascular fitness, or a lack of compliance (2) . It is still a matter of debate how effective moderate physical activity is at maintaining REE and improving the metabolic risk profile. However, this remains an important question, given that it can more easily be performed by overweight people and therefore is associated with a better chance of compliance under day-to-day conditions.
We designed a randomized, 12-wk, 2-arm, parallel, controlled trial to investigate the effects of a moderate yet regular walking program on body weight and body composition, REE, and endocrine and CVD risk variables in overweight and obese participants on a DI. This intervention was compared with a second group on the same diet but without the walking program. We hypothesized as our primary outcome that the walking program would enhance body fat loss and minimize loss of lean mass compared with the diet group without walking program.
Methods
Participants. One hundred sixty-one overweight or obese participants were recruited from the community of the city of Muenster (Germany) by an advertisement in the local newspaper. The volunteers had to meet the following inclusion criteria: age, 25-50 y; BMI (in kg/m 2 ), 27-35; and a sedentary lifestyle. Exclusion criteria were smoking; pregnancy and lactation; menopause; a history of atherosclerotic, renal, gastrointestinal, or endocrine diseases; food allergies or intolerances; and a customary vegetarian or vegan diet. Each volunteerÕs health status was ascertained by physical assessments (body height, weight, blood pressure, heart rate, waist and hip circumference) and medical anamneses, with the use of the Health Questionnaire, Level III, of the German Society of Sports Medicine and Prevention (21) . In cases of uncertainty regarding medical events, an additional checkup (e.g., ultrasound examination of the heart and the carotid artery) was performed by the physician.
After screening, 91 participants were included in the study. They were randomly assigned to 2 intervention groups, a diet-only (DI) and a dietplus-walking (DI + walking) group. During the study, 2 participants from the DI group and 7 participants from the DI + walking group dropped out because of personal reasons or noncompliance with the protocol (Figure 1) . Thus, 82 participants (36 men, 46 women) completed the study, 44 in the DI group and 38 in the DI + walking group. Baseline characteristics are in Table 1 . Only data from participants who completed the study were analyzed and included in this report.
The protocol and objectives of the study were explained to all participants in detail, and all gave their written consent. The study protocol was approved by the Ethics Committee of the University of Muenster and was in accordance with the Helsinki Declaration. The study was registered at www.germanctr.de/ and http://apps.who. int/trialsearch/ as DRKS00006827.
Design. The study was conducted in a parallel design and consisted of a 12-wk intervention period. During this time, the participants underwent a weight-reduction program consisting of a DI only (DI group) or a DI plus fixed moderate physical activity, consisting of brisk walking (DI + walking group). At the beginning of the study (week 0), all participants completed a 3-d dietary record to estimate their habitual energy and nutrient intake. The records had to be completed by the participants on 3 consecutive days, including 2 weekdays and 1 d of the weekend. During and at the end of the study (weeks 6 and 12), 2 further dietary records were completed to assess adherence to the prescribed diet. At the same time points, all participants recorded their activities using a 3-d activity diary, which was also used to verify compliance to the study protocol. These data were used to calculate total energy expenditure (TEE; see below).
Measurements of body weight and waist circumference were made at the beginning, at week 6, and at the end of the study. Body composition, REE, blood pressure, and heart rate were measured at the beginning and end of the study.
Dietary intervention and physical activity. Both groups received the same DI. According to national and international guidelines, a daily dietary energy deficit of 2092-3347 kJ/d (500-800 kcal/d) is recommended for moderate body weight reduction (1) . Thus, the diet was calculated with energy deficits in this range. Based on each individualÕs REE at baseline (see below), they were assigned to one of 3 energy intake groups. Participants with an REE of 5.44-6. , providing 22-25% of total energy as protein. The diet was calculated with 42-45% of energy as carbohydrates and 32-35% of energy as fat. The target for SFAs was <10% of energy, and the energy density (ED; calculated with solid foods only) was calculated to be <5.4 kJ/g (1.3 kcal/g). The study diet and the dietary records were calculated by using the computer-based nutrient calculation program EBISpro, based on the German Nutrient Database Bundeslebensmittelschlü ssel, version 3.01 (Max-Rubner-Institut).
The diet consisted of conventional, mixed foods. The main components were low-fat foodstuffs, e.g., whole-grain bread and cereals, vegetables, and fruits. A particular emphasis was put on the intake of lean, protein-rich foods, such as lean meat and fish, skimmed milk, and low-fat dairy products. No specific recommendations on sodium or salt intake were made, but participants were encouraged not to eat highly processed and fried food, which are usually rich in sodium and salt. The recommended foodstuffs were divided into different groups: 1) bread, rolls, and cereals, 2) starchy side dishes (e.g., pasta, potatoes, rice), 3) milk and milk products, 4) meat and meat products, 5) fish and fish products, 6) fruits, 7) salad and raw vegetables, 8) cooked vegetables, and 9) fats, oils, and dressings. For products (e.g., milk or yogurt) within each group, specific quantity targets were calculated, so that the participants could choose day by day from different products.
All participants received identical and detailed instructions regarding the prescribed diet from a trained nutritionist. They obtained instruction booklets listing the foods to be consumed daily in their respective amounts as well as the foods that were prohibited. In addition, they were given specific recipes and examples for their daily menu. The participants were provided with kitchen scales for weighing the prescribed amounts. To provide support and motivation, every participant received nutrition counseling by a nutritionist at baseline and after 6 wk. Additionally, the participants were called at home by the same nutritionist every week for the first 6 wk and every other week for the last 6 wk of the program to ensure compliance with the diet and to answer questions of the participants.
Participants in the DI group were instructed not to change their usual activities. Participants in the DI + walking group were instructed to perform a physical activity program consisting of brisk walking for a total of 3 h/wk supervised by a licensed fitness trainer, who met with the DI + walking group once a week for 1 h of walking outdoors. The other 2 h were performed by the participants at home. Participants had to walk with a mean speed of 6 km/h, which was measured with the use of a professional sports watch (SUUNTO t3c Black Arrow) and foot-pod (SUUNTO Foot Pod mini).
During the intervention period, every participant had to keep a study log where the dates and times of the different appointments were listed, e.g., dates of blood sampling, nutrition counseling, and when the 3-d dietary and activity protocols had to be filled out. The participants had to write down if they were ill and/or took additional medications other than those assessed during screening. Also, the DI + walking group had to list their walking activity for every week. These data were used to calculate the mean walking time per week.
The energy cost of the walking activities and the TEE in both groups were calculated by multiplying the measured REE (see below) by the energy cost of their physical activity obtained from the metabolic equivalent values listed in the study by Ainsworth et al. (22, 23) . Anthropometrics. Body height was determined by using an ultrasound instrument to the nearest 0.1 cm. Body weight was measured in light clothing, without shoes, with the use of a digital scale (Seca 703), to the nearest 100 g. Waist circumference was measured midway between the lowest rib and the iliac crest, while the participant was at minimal respiration. Hip circumference was measured at the level of trochanteres majores. Both measurements were performed in duplicate in an upright position. Body composition was assessed by bioelectrical impedance analysis (Nutrigard-M) (24) and according to the European Society for Clinical Nutrition and Metabolism guidelines for the standardized examination of outpatients (25) . Measurement was conducted in a supine position with a frequency of 50 kHz. To archive standardized body hydration, participants had to fast, were not allowed to consume any kind of alcohol, and should not have performed physical exercise for $8 h before measurement (25) . FFM was calculated according to Sun et al. (26) and FM by subtracting FFM from body mass.
Blood pressure and heart rate. Blood pressure and heart rate were measured in duplicate in an upright position with an automatic blood pressure measurement device (Boso Medicus Control) under conditions standardized according to the recommendations of the AHA Council on High Blood Pressure Research (27) . The mean arterial pressure (MAP) was calculated as follows: diastolic blood pressure + 1/3 (systolic blood pressure 2 diastolic blood pressure).
REE. REE was measured by using the ventilated hood system (Quark RMR Indirect Calorimetry) under controlled conditions according to recommendations for ambulant patients (28, 29) . Participants arrived at the research center between 0600 and 0900 after an overnight fast. Women were measured during the follicular phase of their menstrual cycle according to self-reported information. After the subject was lying still for 5-10 min in a dimly lit room and covered with a light blanket, the hood was placed over the head of the participant with his or her shoulders covered by a plastic cap to prevent air leakage. The room temperature was kept stable at 21.5°C. Before each measurement, the system was calibrated by using a standard test gas containing 16% oxygen and 5.04% carbon dioxide. The gas pressure was kept constant at 5 bar. Measurements were commenced 10 min after a steady state for maximal carbon dioxide uptake (VCO 2 ) and maximal oxygen uptake (VO 2 ) was reached and were continued for 25 min. The fraction of expired CO 2 was between 0.6% and 1.0%, and the respiratory quotient (RQ, VCO 2 production in liters divided by VO 2 in liters) was between 0.7 and 1.0. Analysis was performed by using CPET Software Suite, Version 8.1a. Variations during the measurements, due to mild hyper-or hypoventilation, were included in the analysis. VO 2 and VCO 2 were converted to REE by using the abbreviated Weir equation (30) .
Blood sampling, processing, and analysis. Venous blood samples were obtained after an overnight fast of $8 h under standardized conditions at the beginning and the end of the study period. The participants were asked to abstain from alcohol for 24 h and were told to not engage in strenuous exercise on the day before blood sampling. Blood was drawn into tubes containing EDTA, lithium heparin, sodium fluoride, or no additives (Sarstedt). Plasma and serum were obtained by centrifugation at 2000 3 g for 15 min at 5°C. Plasma and serum aliquots were immediately frozen in cryovials and stored at 280°C until analysis. All laboratory measurements were performed without knowledge of the intervention group. All samples from a single participant were analyzed in the same assay run. Serum total cholesterol was assayed by using polychromatic endpointmeasurement, serum LDL cholesterol, HDL cholesterol, and TGs, and plasma glucose was quantified by dichromatic endpoint-measurement. Serum thyroid-stimulating hormone, free serum thyroxine, and free serum triiodothyronine were measured by using a homogeneous, sequential, chemiluminescent immunoassay based on LOCI technology with the Dimension Vista 1500 analyzer.
Serum non-HDL cholesterol was calculated by subtracting HDL cholesterol from the total cholesterol concentration. Serum insulin and cortisol were measured by using a chemiluminescent-immunometric assay with the Immulite 2000 analyzer. Insulin resistance was estimated by using the homeostatic model assessment, calculated as the product of fasting serum insulin (expressed as mU/mL) and fasting plasma glucose (expressed as mmol/L), divided by 22.5 (31).
Statistical analysis. All statistical analyses were performed by using SPSS, version 20 (IBM Corporation). The distribution of the data was checked by using normal plots and histograms and by performing Kolmogorov-Smirnov and Shapiro-Wilk tests. Differences between sexes at screening were evaluated by using unpaired StudentÕs t or MannWhitney U tests. Comparison of normally distributed data between groups (changes baseline compared with end) was performed using the unpaired StudentÕs t test and within a group using the paired StudentÕs t test. Data that were not normally distributed were compared by using Mann-Whitney U and WilcoxonÕs Signed Rank tests. Changes in body weight were analyzed by repeated-measures ANOVA. In all cases, P < 0.05 (2-sided) was considered significant. Data are represented as means 6 SDs. All analyses are presented on a per-protocol basis.
Results
Baseline characteristics, dietary intake, and potential side effects. Baseline characteristics of the participants are presented in Table 1 for the group as a whole and for men and women separately. According to selection criteria, all participants were overweight (32.9%) or obese (67.1%). We observed sex differences with respect to body height, body mass, total FM, systolic blood pressure, TGs, total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol, and REE (Table 1) .
Self-reported dietary intakes of energy, macronutrients, and dietary fiber at baseline (habitual diet) and during the intervention (study diet) are given in Table 2 . Based on the dietary records, all participants showed good compliance with the prescribed energy-restricted diet. Compared with baseline, the daily energy intake during the intervention was reduced by 4. In addition, the ED of the study diet was significantly lower than that of the habitual diet (Table 2 ). There were no significant differences in the mean daily intake of energy and nutrients between the DI + walking and the DI group (data not shown).
Participants did not report any side effects or adverse events, neither during the energy-restricted diet nor during the moderate walking program. Because participants gave positive feedback regarding the intervention during the telephone calls and because there was a dropout rate of only 9 participants [9.9%; DI + walking: n = 7 (15.6%); DI: n = 2 (4.3%)], we deduce that the energy-restricted diet was well tolerated.
Changes in body weight, body composition, and waist circumference. Compared with baseline, body weight significantly decreased in both groups by ;8% during the 12-wk intervention ( Figure 2, Table 3 ). No significant intergroup differences were observed. The dietary intervention significantly reduced mean BMI from obesity stage 1 (BMI 30-35) to overweight (BMI 25-29.9) in both groups. The decreases in body weight and BMI were accompanied by a significant reduction in total FM, which was significantly more pronounced in the DI + walking group than in the DI group (Table 3 ). In addition, FFM, waist circumference, and waist-to-height ratio were significantly reduced by both interventions but without significant intergroup differences (Table 3) .
Changes in REE, TEE, RQ, and physical activity. Compared with baseline, REE did not significantly change throughout the intervention and was not significantly different between groups ( Table 4) . RQ values significantly decreased in both treatment groups but were not different between groups (Table 4) . Participants in the DI + walking group walked 2.5 6 0.9 h/wk on average, resulting in an additional daily energy expenditure of 598 6 234 kJ (data not shown). Compared with baseline, TEE and total physical activity (metabolic equivalent hour per 24 h), including walking according to the program, significantly increased in the DI + walking group but not in the DI group (Table 4) .
Changes in blood pressure, heart rate, and clinical and biochemical variables. Compared with baseline, systolic blood pressure decreased in the DI group but not in the DI + walking group, whereas significant decreases in diastolic blood pressure and MAP were observed in both study groups ( Table 5) . Heart rate significantly decreased in both groups, whereby the decrease in the DI + walking group was significantly greater than in the DI group (Table 5) .
Serum TGs and total cholesterol significantly decreased in the DI + walking group but not in the DI group (Table 5 ). In addition, both treatments significantly decreased LDL cholesterol and non-HDL cholesterol, whereas HDL cholesterol and plasma glucose remained unchanged. For all these variables, no significant intergroup differences were observed. In the DI + walking group, we also found a significant decrease in serum insulin and the HOMA-IR index, which was not found in the DI group and which led to a significant difference between the groups in the change in serum insulin (Table 5) .
Serum free triiodothyronine significantly decreased in both groups, while serum free thyroxine remained unchanged during the study. In the DI + walking group, we also found a significant decrease in thyroid-stimulating hormone, which was not found in the DI group. Cortisol significantly increased in both groups but was not different between groups (Table 5 ).
Discussion
The aim of the present randomized, controlled dietary study of overweight or obese but otherwise metabolically healthy participants was to investigate the effects of an energyrestricted diet, with and without moderate walking, on body weight, body composition, waist circumference, waist-to-height ratio, REE, and endocrine and cardiometabolic risk parameters. Our major findings were that body weight, waist circumference, waist-to-height ratio, diastolic blood pressure, MAP, fasting serum LDL cholesterol, and non-HDL cholesterol were significantly improved to a similar extent by both interventions. Weight reductions were not followed by decreases in REE. However, additional moderate walking enhanced the effects of a DI on FM loss and fasting insulin.
We defined the composition of the study diet based on international guidelines for diet-induced weight loss (1) and adapted the daily amount of protein according to current knowledge about how the preservation of absolute protein intake affects metabolic targets for weight loss and weight maintenance during a negative energy balance (32) . The study diet consisted of low-fat foodstuffs such as vegetables, fruits, whole-grain products, lean meat, low-fat milk products, and plant oils (rapeseed or olive oil) as the main source of dietary fat. It had a favorable FA composition, being low in SFA but containing a high proportion of unsaturated FAs. In addition, it was rich in dietary fiber and had a low ED (Table 2) . We believe that the low-ED food pattern, leading to high satiety, was the principal reason for the high levels of compliance shown by our participants, as illustrated by the low dropout rates during the study and the compliance with dietary prescriptions. The necessary energy restriction was facilitated by a high level of practicality for the participants and resulted in pronounced losses in weight and body fat. A reduction in dietary ED was also associated with successful weight loss in other studies (33) (34) (35) (36) . Whitney U tests. ** , ***Difference between the study diet and the habitual diet: **P , 0.01, ***P , 0.001. 2 Data were calculated from 3-d food diaries. 3 Total fat consisted of ;95% FAs with the other ;5% made up of glycerol and other lipids. 4 Energy density was calculated for solid foods without energy-containing beverages. 
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The intensive and ongoing dietary counseling throughout the study may have been a second important factor that determined the high level of adherence to the diet, as suggested by others (37) . The regular walking program conducted by the physical activity group was based on recommendations of the American College of Sports Medicine for appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults (38) . The walking program was well accepted by our participants, and it is suitable for a long-term lifestyle change.
The body weight loss of~8% achieved by both study groups is similar to that reported previously for individuals who are preobese or in obesity stage 1 and are exposed to a mean daily energy deficit of 2092-3347 kJ (500-800 kcal) over 3-6 mo (33, (39) (40) (41) (42) (43) . The changes in body composition observed were consistent with the weight loss being predominately composed of FM (Table 3 ). The larger FM loss caused by the DI + walking intervention may be attributed to the greater TEE compared with the DI group (Table 5) . Our results confirm previous reports that showed that loss of FM is enhanced when dietary energy restriction is combined with physical training (44, 45) . BMI, waist circumference, and weight-to-height ratio were also improved in both groups of participants. Weight-to-height ratio is an index of adiposity that more accurately predicts cardiometabolic risk associated with central obesity than do BMI or waist circumference (46, 47) . REE was not decreased by moderate energy restriction and body weight loss, consistent with other studies that reported preservation of REE after weight loss achieved with the use of diets with increased protein content (48, 49) . However, our findings differ from those of Luscombe-Marsh et al. (50) (51) (52) , who showed that REE was reduced after weight loss and that the reduction was not affected by the protein-to-fat ratio of the diet. By contrast, a meta-analysis of intervention studies, which compared the effects of energy-restricted high-protein (range,
, low-fat diets on weight loss, body composition, and REE, found that there was significantly greater weight loss and less reduction in REE on a high-protein diet (53) .
Energy restriction was associated with a decrease in serum triiodothyronine in both groups. Similar endocrine changes have been observed in other weight-loss studies (54, 55) and may be explained by the regulatory role of triiodothyronine in adaptive thermogenesis and REE. In the recently revisited Minnesota Starvation Experiment, subsequent refeeding after energetic restriction significantly increased plasma triiodothyronine (54) . Energy restriction was also associated with an increase in fasting serum cortisol in both study groups (Table 5 ). Visceral obesity is associated with increased activity of the hypothalamic-pituitaryadrenal (HPA) axis, and this may be in part because of specific qualities of visceral adipose tissue (56) . Previous studies on the effects of energy restriction on the HPA axis function in obese people showed a great deal of variability, with reports of increased, unchanged, or decreased circulating cortisol levels (56) . As the recent nutritional status influences the HPA axis, and because changes in the HPA axis activity can be masked by feedback regulation by glucocorticoids, Seimon et al. (56) proposed that a more complete understanding of any adaption in the HPA axis occurring with energy restriction in obesity would be obtained if investigations were undertaken at several time points during energy restriction rather than just after a period of postrestriction refeeding.
The observed decrease in blood pressure during loss of body fat is similar to results from previous weight-loss studies that used different energy-restricted diets (57) (58) (59) (60) . 20.92 mm Hg/kg body weight loss, respectively. Although the exact mechanisms underpinning the relation between obesity and elevated blood pressure and the effect of body weight loss on blood pressure are unknown, there are several biological pathways that may be involved. For example, the adipose renin-angiotensin-aldosterone system is hyperactivated in obese individuals, and renin activity and aldosterone concentrations are higher than in lean individuals (62) . In addition, activity of the sympathetic nervous system is increased in hypertensive obese individuals, which could induce renal effects (63) . Decreased insulin sensitivity and hyperinsulinemia as part of the metabolic syndrome might also provide an essential link between obesity, sympathetic nervous activation, and hypertension, and energy restriction is known to improve insulin sensitivity 62, 64) . In the present trial, participants did not show poor insulin sensitivity or hyperinsulinemia at baseline. However, fasting serum insulin and HOMA-IR values were significantly reduced in the DI + walking group. The magnitude of the hypotensive effect observed in this trial and previously during weight loss (61) would be clinically meaningful when considered at the population level, particularly in view of the large population of people with pre-and stage I hypertension (65) . In accordance with previous weight loss studies (66, 67) , we found a significant decrease in fasting serum LDL cholesterol after 12 wk in both study groups. Initial body weight and baseline serum LDL cholesterol have been identified as strong predictors of the LDL response (68, 69) . The decrease in LDL cholesterol in the present study can be attributed to weight loss and the favorable dietary composition (69) , especially the FA composition. Compared with the participantsÕ habitual diet, our intervention led to a distinct decrease in SFA ( Table 5 ). The marked effect of high dietary SFA increasing serum LDL cholesterol is well known (69, 70) . Long-chain SFA (C12:0-C16:0) reduces the activity of LDL receptors and thereby decrease cellular LDL uptake (71, 72) .
Both interventions significantly reduced serum non-HDL cholesterol. Evidence was provided that non-HDL cholesterol can more accurately predict cardiovascular risk than LDL cholesterol can, because it encompasses all cholesterolcontaining atherogenic particles including LDL cholesterol and VLDL cholesterol (73) . In the third Adult Treatment Panel guidelines of the US National Cholesterol Education Program, non-HDL cholesterol was introduced as a secondary target of therapy for persons with $200 mg TGs/dL (74) . The literature regarding lifestyle interventions for weight loss and non-HDL cholesterol reduction is limited. However, consistent with our findings, Dow et al. (68) demonstrated significant decreases in serum non-HDL cholesterol after 12 and 24 mo of weight loss by overweight and or obese women. An additional benefit of weight loss is the lowering of TGs, which promotes the remodeling of LDL into larger, less atherogenic particles (69, 75) . However, TGs were only decreased in the DI + walking group but not relative to the DI group. This is likely the result of higher baseline values in the DI + walking group (2.14 6 1.97 mmol/L) than in the DI group (1.51 6 0.64 mmol/L).
In the DI + walking group, fasting serum insulin and HOMA-IR values fell significantly after the 12-wk intervention. These data demonstrate the effectiveness of moderate energy restriction (500-800 kcal/d) plus a regular walking program (2.5 h/wk) for improvement of insulin sensitivity.
One strength of this study is its free-living setting, whereby no food was provided to the participants. However, accurate assessment of the dietary compliance was difficult. Reported energy intakes during the trial in the DI + walking group and the DI group were hypoenergetic, which supported the decrease in body weight and FM. Furthermore, according to analysis of their food diaries, both groups reported good compliance with their food recommendations. A further strength of our intervention trial is the low dropout rate of 9.9%. However, the dropout rate differed between the 2 intervention groups (DI, 4.3%; DI + walking, 15.6%) leading to different and slightly unbalanced sample sizes of the 2 groups (n = 38 compared with 44). This might have reduced the power to detect significant intergroup differences in some variables. This study focused on weight, REE, and specific risk factors for cardiometabolic diseases as endpoints. We did not evaluate the effect of the interventions on other important clinical variables, such as renal and liver function, bone turnover, inflammation, cardiorespiratory fitness, cognitive variables (e.g., hunger, satiety), and neuropsychological outcomes. The relatively short duration (12 wk) of this study and the fact that we did not include a weight-loss maintenance phase are further limitations. Furthermore, our free-living study design and the applied methods do not allow us to quantify or to predict the dose effect of energy restriction. For this, we would have used a strictly controlled study setting with subjects living under strictly controlled study conditions. In addition, other methods with higher precision for the calculation of energy intake, energy expenditure, and body composition had to be applied. These are, e.g., measurement of energy intake with a fully weighed dietary record or with full provision of the diet, measurement of energy expenditure in a respiration chamber or with doubly labeled water, and measurement of body composition with hydrodensitometry and isotope dilution. These methods, however, were not applicable in the free-living setting of our study.
In the present study, our subjects were grouped into different energy intake groups based on each individually measured REE at baseline as described. In our previous study (60) we used the total energy intake estimated from 3-d dietary records as the basis. There is no scientific consensus about the best approach for calculating an energy deficit in adults. Based on our results and study experience, we cannot decide which approach is better or inferior to calculate an energy deficit. Both approaches are suitable and lead to a significant decrease in body weight.
In conclusion, participation in a weight loss study resulted in significant reductions in body weight, BMI, FM, and waist circumference after 12 wk in overweight and obese free-living participants. This moderate weight loss was associated with significant improvements in cardiometabolic risk factors and was not followed by a decrease in REE. Additional moderate walking enhanced the effects of a DI to induce fat loss and reduce fasting serum insulin.
